Roderick John Flower

This profile gathers the share dealings of Roderick John Flower in Antibe Therapeutics Inc. In total, 18 filings cover trades dated from 19 April 2018 to 11 January 2024.

Every open-market trade on record is a sale: 2 sales worth €97k. Outside the open market, there are 13 option exercises.

The latest filing, published on 13 January 2024, reports an option exercise of €9,716 in Antibe Therapeutics Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.